6 enregistrements totalisant 609,440.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
| Conseil national de recherches Canada | $609,440 | 6 enregistrements |
Stabilization of multiple viral vector platforms with PT120-D to produce strong preclinical evidence of impact.
Optimization of ultra-stable formulation for viral vectored vaccine, compatible with oral dosing
As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored va...
Develop a rapid assay platform to support rapid testing and screening of a vast array of formulations to support our goal of increasing the stability of antibody based therapeutics.
The Project will support development of intellectual property capacity within the Firm.
The project will support development of intellectual property capacity within the firm.